Thymoma-associated myasthenia gravis: Clinical features and surgical results

被引:7
|
作者
Bouchikh, M. [1 ,2 ]
El Malki, H. O. [2 ]
Ouchen, F. [1 ]
Achir, A. [1 ]
Benosman, A. [1 ]
机构
[1] CHU Ibn Sina, Serv Chirurg thorac, Rabat Principale 10001, Morocco
[2] Univ Mohamed V Souissi, Fac Med & Pharm Rabat, CRECET, Rabat 8007, Morocco
关键词
Myasthenia gravis; Thymoma; Surgery; Thymectomy; Complete stable remission; THYMECTOMY; PREDICTORS;
D O I
10.1016/j.neurol.2013.01.625
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Objective. The aim of this study was to compare the characteristics of myasthenic patients with and without thymoma, and the results of thymectomy in both types of patients. Material and methods. - A retrospective study was conducted among 66 patients who underwent thymectomy for myasthenia gravis in our department over a 10-year period (2000-2010). The surgical approach was sternotomy or anterolateral thoracotomy. Patients were divided into two groups according to the presence of thymoma: with (T-MG) and without (NT-MG) thymoma. Complete stable remission (CSR) was the primary endpoint. Results. - Median age was 35.09 +/- 9.89 years. The NT-MG group had 38 patients (57.57%) and the T-MG group 28 patients (42.43%). There was no difference between the two groups regarding the surgical approach (P = 0.52). T-MG patients were older (40.54 +/- 15.16 vs. 31.37 +/- 9.46) (P = 0.008) and predominantly male. There were more generalized forms (P = 0.01) and more bulbar involvement (P = 0.02) in the T-MG group. The rate of CSR at 5 years was 7% and 17% in the T-MG and NT-MG patients respectively (P = 0.70). At 10 years, it was 36% and 94.73% respectively (P = 0.03). Conclusion. - Thymomatous myasthenia gravis is characterized by the severity of its clinical features. Remission rate at 10 years was significantly lower in the myasthenia with thymoma group. (C) 2013 Elsevier Masson SAS. All rights reserved.
引用
收藏
页码:879 / 883
页数:5
相关论文
共 50 条
  • [41] Multimodal immunotherapy ameliorates myasthenia gravis preceded by thymoma-associated multiorgan autoimmunity
    Kasahara, Hiroo
    Shimizu, Kazuki
    Makioka, Kouki
    Sano, Takaaki
    Ohtaki, Yoichi
    Ikeda, Yoshio
    IMMUNOLOGIC RESEARCH, 2022, 70 (03) : 414 - 418
  • [42] Netrin-1 receptor antibodies in thymoma-associated neuromyotonia with myasthenia gravis
    Torres-Vega, Estefania
    Mancheno, Nuria
    Cebrian-Silla, Arantxa
    Herranz-Perez, Vicente
    Chumillas, Maria J.
    Moris, German
    Joubert, Bastien
    Honnorat, Jerome
    Sevilla, Teresa
    Vilchez, Juan J.
    Dalmau, Josep
    Graus, Francesc
    Manuel Garcia-Verdugo, Jose
    Bataller, Luis
    NEUROLOGY, 2017, 88 (13) : 1235 - 1242
  • [43] Myasthenic crisis in thymoma-associated myasthenia gravis: a multicenter retrospective cohort study
    Huan, Xiao
    Ruan, Zhe
    Zhao, Rui
    Su, Manqiqige
    Ning, Fan
    Zou, Zhangyu
    Tan, Song
    Luo, Lijun
    Yang, Song
    Shi, Jianquan
    Liu, Yanping
    Jiang, Qilong
    Xi, Jianying
    Chang, Ting
    Luo, Sushan
    Zhao, Chongbo
    NEUROMUSCULAR DISORDERS, 2023, 33 (10) : 782 - 787
  • [44] Treatment of Thymoma-Associated Myasthenia Gravis With Stereotactic Body Radiotherapy: A Case Report
    Lee, Caroline M.
    Lee, Jason D.
    Hobson-Webb, Lisa D.
    Bedlack, Richard S.
    Salama, Joseph K.
    ANNALS OF INTERNAL MEDICINE, 2016, 165 (04) : 300 - 301
  • [45] Thymoma-associated exfoliative dermatitis with post-thymectomy myasthenia gravis in a cat
    Singh, Ameet
    Boston, Sarah E.
    Poma, Roberto
    CANADIAN VETERINARY JOURNAL-REVUE VETERINAIRE CANADIENNE, 2010, 51 (07): : 757 - 760
  • [46] THYMOMA AND MYASTHENIA-GRAVIS - CLINICAL AND IMMUNOLOGICAL FEATURES
    AARLI, JA
    GILHUS, NE
    HALVORSEN, JF
    VARHAUG, JE
    ACTA NEUROLOGICA SCANDINAVICA, 1988, 77 : 123 - 123
  • [47] THYMOMA-ASSOCIATED MYASTHENIA GRAVIS AND INCLUDED BODY MYOSITIS: AN UNUSUAL COMBINATION OF DISEASES
    Pontecorvo, S.
    Di Blasi, C.
    Morreale, M.
    Francia, A.
    Prencipe, M.
    JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM, 2009, 14 : 121 - 121
  • [48] Two cases of thymoma-associated myasthenia gravis without antibodies to the acetylcholine receptor
    Maggi, Lorenzo
    Andreetta, Francesca
    Antozzi, Carlo
    Confalonieri, Paolo
    Cornelio, Ferdinando
    Scaioli, Vidmer
    Mantegazza, Renato
    NEUROMUSCULAR DISORDERS, 2008, 18 (08) : 678 - 680
  • [49] ANTI-CARDIAC RYANODINE RECEPTOR ANTIBODIES IN THYMOMA-ASSOCIATED MYASTHENIA-GRAVIS
    MYGLAND, A
    TYSNES, OB
    MATRE, R
    AARLI, JA
    GILHUS, NE
    AUTOIMMUNITY, 1994, 17 (04) : 327 - 331
  • [50] Dexamethasone improves thymoma-associated myasthenia gravis via the AKT-mTOR pathway
    Yuxin Liu
    Si Chen
    Yan Wang
    Zeyang Zhang
    Hui Zhang
    Ziyi Wang
    Ziyou Tao
    Jianyao Wang
    Peng Zhang
    Naunyn-Schmiedeberg's Archives of Pharmacology, 2024, 397 : 817 - 828